Newport Healthcare is the nation’s leading provider of behavioral healthcare for adolescents and young adults. Our residential and outpatient programs for ages 12–35 are located across the United States, and our PrairieCare division in Minnesota provides a full continuum of care, from an inpatient psychiatric hospital for ages 28 and under, through outpatient services for all ages. This report tracks the outcomes of our integrated, multidisciplinary model of care, which brings together an exceptional range of clinical and medical expertise. Our treatment teams incorporate a wide variety of specializations—clinical, medical, psychiatric, experiential, dietary, and life skills/academic—to create transformative care experiences with long-lasting results. In 2023, Newport’s treatment yielded remarkable improvements in adolescent and young adult patients’ depressive and anxiety symptoms, subjective well-being, suicide risk, and attachment to parents/caregivers. In addition, outcomes data on Transcranial Magnetic Stimulation (TMS) from our PrairieCare TMS clinics shows significant improvement in patients’ depressive symptoms throughout the course of treatment. Highlights from the Report Newport treatment resulted in the following outcomes: Anxiety levels reduced from severe to mild, on average, for adolescents in residential care Well-being improved from “poor” to “well,” on average, for all patients Depressive symptoms decreased by 50% for young adults in residential care Percentage of outpatients reporting suicide plans dropped from 16% to 2% 40% of patients experienced remission from treatment- resistant depression after TMS treatment at PrairieCare